Emergent BioSolutions (EBS) Misses Q1 EPS by 22c, Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| EMERGENT BIOSOLUTIONS, Inc. (NYSE: EBS) | Delayed: 6.10 -0.13 (2.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $6.23 | 52 Week High | $44.38 | |||
| Open | $6.20 | 52 Week Low | $24.47 | |||
| Day High | $6.23 | P/E | 305.00 | |||
| Day Low | $6.01 | EPS | $0.02 | |||
| Volume | 131,893 | |||||
